Paracetamol intravenous

Drug Profile

Paracetamol intravenous

Alternative Names: Acelio; acetaminophen IV; Acetavance; IV APAP; Ofirmev; Perfalgan; TRM-1106

Latest Information Update: 29 Nov 2016

Price : $50

At a glance

  • Originator Pharmatop
  • Developer Bristol-Myers Squibb; Mallinckrodt plc; Terumo
  • Class Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Prostaglandin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Fever; Pain

Most Recent Events

  • 18 Nov 2016 Mallinckrodt Pharmaceuticals completes a Pharmacokinetics trial in United Kingdom
  • 08 Nov 2016 The US FDA approved a Prior Approval Supplement for acetaminophen injection
  • 01 Aug 2016 Cadence Pharmaceuticals completes a phase III trial for Pain (in children) in USA (NCT01635101)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top